Picton Mahoney Asset Management reduced its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 119,300 shares of the healthcare conglomerate’s stock after selling 5,600 shares during the period. Picton Mahoney Asset Management’s holdings in UnitedHealth Group were worth $26,302,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Exane Derivatives raised its position in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after acquiring an additional 460 shares in the last quarter. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group in the second quarter worth $114,000. Acrospire Investment Management LLC increased its position in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the period. Jacobi Capital Management LLC increased its position in UnitedHealth Group by 6.6% in the second quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock worth $136,000 after buying an additional 45 shares during the period. Finally, Baystate Wealth Management LLC increased its position in UnitedHealth Group by 64.9% in the fourth quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock worth $186,000 after buying an additional 300 shares during the period. 86.83% of the stock is currently owned by institutional investors and hedge funds.
In other news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 10,400 shares of the firm’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $229.87, for a total value of $2,390,648.00. Following the transaction, the director now directly owns 1,781,657 shares of the company’s stock, valued at approximately $409,549,494.59. The disclosure for this sale can be found here. Insiders have sold 53,196 shares of company stock worth $12,291,179 over the last three months. Corporate insiders own 0.89% of the company’s stock.
UnitedHealth Group Inc (NYSE UNH) opened at $222.77 on Tuesday. The company has a market capitalization of $215,570.00, a price-to-earnings ratio of 23.45, a PEG ratio of 1.31 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a fifty-two week low of $162.74 and a fifty-two week high of $250.79.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the company earned $2.11 earnings per share. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.
TRADEMARK VIOLATION NOTICE: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/03/13/picton-mahoney-asset-management-reduces-position-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.